Medibiofarma cierra nueva ronda de financiación por valor de 1,

by Palobiofarma

Medibiofarma ha cerrado una ronda de financiación de 1,2 millones de euros, con el apoyo financiero de su equipo promotor y otros socios de contrastada experiencia en el ámbito de la salud y la tecn...

Read more

ORYZON announces FDA approval of IND for FRIDA, a Phase Ib trial with iadademstat in R/R AML FLT3mut+ patients

by Oryzon Genomics

Oryzon Genomics has announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that its Investigational New Drug application (IND) for iadademstat is now approv...

Read more

A study with the participation of VHIO leads to approval of first-line treatment with pembrolizumab for most patients with metastatic or recurrent head and neck squamous cancer

by VHIO

Pembrolizumab, a monoclonal antibody which binds with the protein PD-1 to help immune cells destroy more cancer cells, is seeing a steady increase in its indications. Now, the KEYNOTE-048 phase III cl...

Read more

CNIO researchers find a way to increase effectiveness of radiotherapy for brain metastasis

by CNIO - Centro Nacional de Investigaciones Oncológicas

They found that a simple blood test can help detect patients with resistance to brain radiotherapy and identified a drug that might reverse it. A multi-centre clinical study is now under way to valida...

Read more

A study participated by Vall Hebron made possible the approbation of a new treatment for severe pediatric asthma

by Vall d’Hebron

An international clinical trial has demonstrated the effectiveness of dupilumab in reducing patients’ asthmatic exacerbations, improving their and their relatives quality of life

Read more

Se inicia el ensayo clínico para el primer tratamiento del síndrome del ovario poliquístico

by Fundació Sant Joan de Déu

La Dra. Lourdes Ibáñez, investigadora del IRSJD y endocrinóloga en el Hospital Sant Joan de Déu Barcelona, lidera un ensayo clínico internacional que evaluará un tratamiento pionero a nivel mund...

Read more

A clinical trial shows the safety and potential of an oncolytic virus against advanced pancreatic cancer

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

El ensayo clínico en fase 1 liderado por el IDIBELL y el ICO muestra que la administración del virus VCN-01 es viable y una posible nueva herramienta en el tratamiento del cáncer de páncreas avanz...

Read more

VHIO is taking part in the development of a latest-generation antibody that will offer an alternative for immunotherapy-resistant tumours

by VHIO

The drug GEN1046 was also tested for the first time in the Phase 1 clinical trial on 61 patients with advanced solid refractory tumours. Here the drug demonstrated immunological-pharmacodynamic effect...

Read more

El Hospital Sant Joan de Déu, primer centro europeo que participa en un ensayo clínico sobre una nueva terapia génica contra el síndrome de Duchenne

by Hospital Sant Joan de Déu

El Hospital Sant Joan de Déu Barcelona es el primer centro europeo que participa en un ensayo clínico desarrollado por por Sarepta Therapuetics en colaboración con Roche, de una terapia génica con...

Read more

RBDCOV initiates the first Phase III clinical trial of HIPRA's Covid-19 vaccine in immunocompromised people

by IdiBGi

This clinical trial will determine whether an additional dose of HIPRA's Covid-19 vaccine can generate an immune response in people living with immune system disorders, such as immunodeficiencies or w...

Read more

Catalonia participates in over 1,200 active clinical trials

by Biocat

Catalonia is participating in over 1,200 clinical trials currently underway to test new therapies and drugs in patients. This puts the BioRegion 6th in Europe in number of trial participations and 8th...

Read more

Un ensayo clínico muestra la seguridad y potencial de un virus oncolítico contra el cáncer de páncreas avanzado

by CIBERONC - Centro de Investigación Biomédica en Red, Cáncer

Los virus oncolíticos son virus modificados genéticamente para reconocer y atacar a las células tumorales. Se trata de un tipo de inmunoterapia innovadora con gran recorrido en el tratamiento contr...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream